AptaBio Therapeutics Inc
KOSDAQ:293780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AptaBio Therapeutics Inc
KOSDAQ:293780
|
KR |
|
T
|
Thai Plaspac PCL
SET:TPAC
|
TH |
|
I
|
IDP Corp Ltd
KOSDAQ:332370
|
KR |
|
E
|
Earthfirst Technologies Inc
OTC:EFTI
|
US |
|
S
|
SYSteel Tech Co Ltd
KOSDAQ:365330
|
KR |
|
Fifth District Bancorp Inc
NASDAQ:FDSB
|
US |
|
I
|
ITEyes Inc
KOSDAQ:372800
|
KR |
|
Profusa Inc
NASDAQ:PFSA
|
US |
|
S
|
Seohee Construction Co Ltd
KOSDAQ:035890
|
KR |
|
D
|
Del Monte Corp
DUS:FDM
|
KY |
Intrinsic Value
Is AptaBio Therapeutics Inc undervalued or overvalued?
See the intrinsic value estimate for AptaBio Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What AptaBio Therapeutics Does
AptaBio Therapeutics is a South Korean biotech company that develops new drug candidates, with a focus on treatments built around its aptamer-based technology. An aptamer is a short piece of synthetic DNA or RNA that can be designed to bind to a specific target, which can help the company create drugs or diagnostic tools aimed at precise disease pathways.
- Headquarters
- Korea KR
- Employees
- 28
- IPO date
- Jun 12, 2019
Revenue & Expenses Breakdown
AptaBio Therapeutics Inc
Earnings Waterfall
AptaBio Therapeutics Inc
The intrinsic value for AptaBio Therapeutics Inc (293780) under the Base Case is hidden KRW.
Compared with the current market price of 5 310 KRW, the stock appears hidden.